tiprankstipranks
Trending News
More News >
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market

Sonoma Pharmaceuticals (SNOA) Financial Statements

Compare
352 Followers

Sonoma Pharmaceuticals Financial Overview

Sonoma Pharmaceuticals's market cap is currently $6.43M. The company's EPS TTM is $-0.129; its P/E ratio is -1.72; Sonoma Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 14.29M$ 12.73M$ 13.27M$ 12.63M$ 18.63M
Gross Profit$ 5.46M$ 4.75M$ 4.48M$ 3.99M$ 6.56M
Operating Income$ -3.71M$ -4.70M$ -4.57M$ -5.89M$ -3.45M
EBITDA$ -3.57M$ -4.53M$ -4.45M$ -5.70M$ -3.22M
Net Income$ -3.46M$ -4.83M$ -5.15M$ -5.09M$ -3.95M
Balance Sheet
Cash & Short-Term Investments$ 5.37M$ 3.13M$ 3.82M$ 7.40M$ 4.22M
Total Assets$ 13.69M$ 14.74M$ 16.23M$ 18.84M$ 14.99M
Total Debt$ 305.00K$ 608.00K$ 849.00K$ 1.37M$ 2.67M
Net Debt$ -5.07M$ -2.52M$ -2.97M$ -6.03M$ -1.54M
Total Liabilities$ 9.28M$ 8.60M$ 8.25M$ 10.15M$ 9.62M
Stockholders' Equity$ 4.41M$ 6.14M$ 7.98M$ 8.70M$ 5.36M
Cash Flow
Free Cash Flow$ -168.00K$ -2.42M$ -6.42M$ -4.38M$ -3.56M
Operating Cash Flow$ -88.00K$ -2.40M$ -6.15M$ -4.25M$ -3.38M
Investing Cash Flow$ -80.00K$ -2.00K$ -258.00K$ -99.00K$ 388.00K
Financing Cash Flow$ 3.03M$ 1.68M$ 2.49M$ 7.40M$ 3.31M
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Sonoma Pharmaceuticals Debt to Assets

Sonoma Pharmaceuticals Cash Flow

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS